Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy

Brain Pathology

Volumn 22, Issue 1, 2012, Pages 58-66

  Jeffrey, Martin ^a   McGovern, Gillian ^a   Chambers, Emily V ^b   King, Declan ^b   González, Lorenzo ^a   Manson, Jean C ^b   Ghetti, Bernardino ^c   Piccardo, Pedro ^b,c,d   Barron, Rona M ^b  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INDIANA UNIVERSITY   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

amyloid plaques; Gerstmann Str ussler Scheinker; neurodegeneration; prion protein; scrapie

Indexed keywords

AMYLOID; PRION PROTEIN;

AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ADHESION; CELL MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; IMMUNOGOLD LABELING; MICROSCOPY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRION DISEASE; SCRAPIE;

ANIMALS; BRAIN; CELL MEMBRANE; DISEASE MODELS, ANIMAL; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; MICE; MICE, TRANSGENIC; NEURITES; NEUROGLIA; PLAQUE, AMYLOID; PRION DISEASES; PRIONS; VACUOLES;

EID: 83555173370     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00508.x     Document Type: Article

References (45)

1. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B, (2002) Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrPSc) into contiguous membranes. EMBO J 21: 1031-1040. (Pubitemid 34206176)
2. Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, Manson JC, (2007) High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 282: 35878-35886. (Pubitemid 350277109)
3. Barron RM, Thomson V, King D, Shaw J, Melton DW, Manson JC, (2003) Transmission of murine scrapie to P101L transgenic mice. J Gen Virol 84: 3165-3172. (Pubitemid 37336801)
4. Caughey B, Baron GS, Chesebro B, Jeffrey M, (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78: 177-204.
5. Caughey B, Raymond GJ, (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase- sensitive. J Biol Chem 266: 18217-18223. (Pubitemid 21908068)
6. Caughey B, Raymond GJ, Ernst D, Race RE, (1991) N-Terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65: 6597-6603.
7. Chesebro B, Race B, Meade-White K, LaCasse R, Striebel J, Klingeborn M, et al, (2010) Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 6: e1000800.
8. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al, (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308: 1435-1439. (Pubitemid 40791292)
9. Chiesa R, Piccardo P, Quaglio E, Drisaldi B, SiHoe SL, Takao M, et al, (2003) Molecular distinction between pathogenic and infectious properties of the prion protein. J Virol 77: 7611-7622. (Pubitemid 36734531)
10. Ersdal C, Goodsir CM, Simmons MM, McGovern G, Jeffrey M, (2009) Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains. Neuropathol Appl Neurobiol 35: 259-271.
11. Gambetti P, Petersen RB, Parchi P, Chen SG, Capellari S, Goldfarb L, et al, (1999) Inherited prion diseases. In: Prion Biology and Diseases, SB Prusiner, (ed.), pp. 509-583. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
12. Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K, et al, (1996) Prion protein amyloidosis. Brain Pathol 6: 127-145. (Pubitemid 26161871)
13. Giaccone G, Verg L, Buggiani O, Frangione B, Servan D, Prusiner SB, et al, (1992) Prion protein preamyloid and amyloid deposits in Gerstmann- Sträussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci U S A 89: 9349-9353.
14. González L, Martin S, BegaraMcGorum I, Hunter N, Houston F, Simmons M, Jeffrey M, (2002) Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie. J Comp Pathol 126: 17-29.
15. Grathwohl SA, Kalin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, et al, (2009) Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12: 1361-1363.
16. Hashimoto K, Mannen T, Nukina N, (1992) Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides. Acta Neuropathol 83: 613-617.
17. Jeffrey M, Goodsir C, McGovern G, Barmada SJ, Medrano AZ, Harris DA, (2009) Prion protein with an insertional mutation accumulates on axonal and dendritic plasmalemma and is associated with distinctive ultrastructural changes. Am J Pathol 175: 1208-1217.
18. Jeffrey M, Goodsir CM, (1996) Immunohistochemistry of resinated tissues for light and electron microscopy. In: Prion Diseases, HF Baker, RM Ridley, (eds), pp. 301-312. Humana Press: Totowa.
19. Jeffrey M, Goodsir CM, Bruce ME, McBride PA, Farquhar C, (1994) Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropathol Appl Neurobiol 20: 535-542.
20. Jeffrey M, Goodsir CM, Bruce ME, McBride PA, Scott JR, Halliday WG, (1994) Correlative light and electron microscopy studies of PrP localization in 87V scrapie. Brain Res 656: 329-343. (Pubitemid 24277118)
21. Jeffrey M, Goodsir CM, Fowler N, Hope J, Bruce ME, McBride PA, (1996) Ultrastructural immuno-localization of synthetic prion protein peptide antibodies in 87V murine scrapie. Neurodegeneration 5: 101-109. (Pubitemid 26132274)
22. Jeffrey M, Goodsir CM, Holliman A, Higgins RJ, Bruce ME, McBride PA, Fraser JR, (1998) Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N terminal specific PrP antibodies in scrapie-affected sheep and mice. Vet Rec 142: 534-537. (Pubitemid 128494338)
23. Jeffrey M, Goodsir CM, Race RE, Chesebro B, (2004) Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann Neurol 55: 781-792. (Pubitemid 38702573)
24. Jeffrey M, McGovern G, Goodsir CM, Gonzalez L, (2009) Strain-associated variations in abnormal PrP trafficking of sheep scrapie. Brain Pathol 19: 1-11.
25. Jeffrey M, McGovern G, Siso S, Gonzalez L, (2011) Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease. Acta Neuropathol 121: 113-134.
26. Jellinger K, Jirasek A, (1971) Neuroaxonal dystrophy in man: character and natural history. Acta Neuropathol 5 (Suppl.): 3-16.
27. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG, (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279: 46363-46366. (Pubitemid 39518276)
28. Kitamoto T, Muramoto T, Hilbich C, Beyreuther K, Tateishi J, (1991) N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler-syndrome. Brain Res 545: 319-321.
29. Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al, (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275: 402-405. (Pubitemid 27051621)
30. Liberski PP, Yanagihara R, Budka H, Gajdusek DC, (1993) Neuroaxonal dystrophy in unconventional slow virus disease. In: Light and Electron Microscopic Neuropathology of Slow Virus Disorders, PP Liberski, (ed.), pp. 269-294. CRC Press: Boca Raton, FL.
31. Liberski PP, Yanagihara R, Gibbs CJJ, Gajdusek DC, (1989) Scrapie as a model for neuroaxonal dystrophy: ultrastructural studies. Exp Neurol 106: 133-141. (Pubitemid 19279479)
32. Manson J, McBride P, Hope J, (1992) Expression of the PrP gene in the brain of Sinc congenic mice and its relationship to the development of scrapie. Neurodegeneration 1: 45-52.
33. Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, et al, (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 18: 6855-6864.
34. McGovern G, Brown KL, Bruce ME, Jeffrey M, (2004) Murine scrapie infection causes an abnormal germinal centre reaction in the spleen. J Comp Pathol 130: 181-194. (Pubitemid 38279335)
35. Parchi P, Chen SG, Brown P, Zou WQ, Capellari S, Budka H, et al, (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A 95: 8322-8327.
36. Piccardo P, Dlouhy SR, Lievens PMJ, Young K, Thomas DP, Nochlin D, et al, (1998) Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57: 979-988. (Pubitemid 28478008)
37. Piccardo P, Ghetti B, Dickson DW, Vinters HV, Giaccone G, Bugiani O, et al, (1995) Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J Neuropathol Exp Neurol 54: 790-801.
38. Piccardo P, Manson JC, King D, Ghetti B, Barron RM, (2007) Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 104: 4712-4717. (Pubitemid 47186290)
39. Prusiner SB, Peters P, Kaneko K, Taraboulos A, Lingappa V, Cohen FE, DeArmond SJ, (1999) Cell biology of prions. In: Prion Biology and Diseases, SB Prusiner, (ed.), pp. 349-391. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
40. Somerville RA, (2002) TSE agent strains and PrP: reconciling structure and function. Trends Biochem Sci 27: 606-612. (Pubitemid 35435309)
41. Tagliavini F, Lievens PMJ, Tranchant C, Warter JM, Mohr M, Giaccone G, et al, (2001) A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem 276: 6009-6015.
42. Tateishi J, Kitamoto T, Hoque MZ, Furukawa H, (1996) Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurol 46: 532-537. (Pubitemid 26081345)
43. Tremblay P, Ball HL, Kaneko K, Groth D, Hegde RS, Cohen FE, et al, (2004) Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 78: 2088-2099. (Pubitemid 38176741)
44. Wadsworth JD, Joiner S, Linehan JM, Cooper S, Powell C, Mallinson G, et al, (2006) Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 129: 1557-1569. (Pubitemid 43999387)
45. Wisniewski HM, Vorbrodt AW, Wegiel J, Morys J, Lossinsky AS, (1990) Ultrastructure of the cells forming amyloid fibres in Alzheimer's disease and scrapie. Am J Med Genet 7: 287-297.